Assuming halt is required, the following results were found.

  • What's New in Stem Cells? Expert Discusses Hematopoietic Status and Newer Mesenchymal Approaches

    The rationale for this approach, also called bone marrow transplant, is: complete removal of the diseased immune system to halt ongoing MS immune-mediated damage to the central nervous system; purified bone marrow stem cells may be capable of fully...

    https://mschristian.org/index.php/what-s-new-in-stem-cells-expert-discusses-hematopoietic-status-and-newer-mesenchymal-approaches
  • COVID-19 and Neuromyelitis Optica Disorder: A Need for Guidance-Based Management - Neurology Advisor

    In their paper, the authors from the University of Buenos Aires wrote that there is also no evidence to suggest clinicians halt immunosuppressant treatment in patients with NMOSD who have been infected by COVID-19. Also, no consensus statement has been...

    https://mschristian.org/index.php/blog/covid-19-and-neuromyelitis-optica-disorder-a-need-for-guidance-based-management-neurology-advisor
  • Research explains why many psychiatric drugs that work in the lab don’t work in people

    Alzheimer’s disease (AD), or the brain tumor glioblastoma complete successful trials in mice but then come to a grinding halt in human trials, wasting billions of dollars in drug research. This is partly because of obvious behavioral differences between...

    https://mschristian.org/index.php/blog/research-explains-why-many-psychiatric-drugs-that-work-in-the-lab-don-t-work-in-people
  • US presidential hopeful Bloomberg plans to ban all flavored vapes

    Former Vice President Joe Biden, who is also running for the Democratic nomination, said earlier this month he would halt the sale of vaping products until more research is done. Category: Uncategorized Original link Original author: GTNF Trust Read More

    https://mschristian.org/index.php/articles/2-uncategorised/9794-us-presidential-hopeful-bloomberg-plans-to-ban-all-flavored-vapes
  • Dementia Life Expectancy; Teens and Opioids; Duchenne Test for Newborns

    Biogen's anti-tau drug, missed its primary endpoint in a progressive supranuclear palsy (PSP) trial; the company will halt PSP studies but will continue testing the drug in Alzheimer's disease. Original link Read More

    https://mschristian.org/index.php/articles/2-uncategorised/9614-dementia-life-expectancy-teens-and-opioids-duchenne-test-for-newborns
  • Research explains why many psychiatric drugs that work in the lab don’t work in people

    Alzheimer’s disease (AD), or the brain tumor glioblastoma complete successful trials in mice but then come to a grinding halt in human trials, wasting billions of dollars in drug research. This is partly because of obvious behavioral differences between...

    https://mschristian.org/index.php/articles/2-uncategorised/8330-research-explains-why-many-psychiatric-drugs-that-work-in-the-lab-don-t-work-in-people
  • Study sheds light on brain cell changes in people with MS

    effective treatments. Those living with progressive forms of MS desperately need new options that repair myelin damage and halt progression. "We believe that one day we can stop MS and projects like this are going to make that happen more quickly."...

    https://mschristian.org/index.php/articles/2-uncategorised/5438-study-sheds-light-on-brain-cell-changes-in-people-with-ms
  • Rethinking neurodegenerative disease treatment: Target multiple pathological proteins

    understand how they progress in patients' brains, with an eye toward clinical studies that combine targeted therapies to halt or slow accumulation of these disease proteins." Additional co-authors include Penn's John L. Robinson, Edward B. Lee, Sharon...

    https://mschristian.org/index.php/articles/2-uncategorised/4250-rethinking-neurodegenerative-disease-treatment-target-multiple-pathological-proteins
  • Dementia Life Expectancy; Teens and Opioids; Duchenne Test for Newborns

    Biogen's anti-tau drug, missed its primary endpoint in a progressive supranuclear palsy (PSP) trial; the company will halt PSP studies but will continue testing the drug in Alzheimer'sdisease. Original link

    https://mschristian.org/index.php/blog/dementia-life-expectancy-teens-and-opioids-duchenne-test-for-newborns
  • Rethinking neurodegenerative disease treatment: Target multiple pathological proteins

    understand how they progress in patients' brains, with an eye toward clinical studies that combine targeted therapies to halt or slow accumulation of these disease proteins." Additional co-authors include Penn's John L. Robinson, Edward B. Lee, Sharon...

    https://mschristian.org/index.php/blog/rethinking-neurodegenerative-disease-treatment-target-multiple-pathological-proteins
  • Study sheds light on brain cell changes in people with MS

    effective treatments. Those living with progressive forms of MS desperately need new options that repair myelin damage and halt progression. "We believe that one day we can stop MS and projects like this are going to make that happen more quickly."...

    https://mschristian.org/index.php/blog/study-sheds-light-on-brain-cell-changes-in-people-with-ms

Results 1 - 11 of 11